Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects including drowsiness, although the medical relevance is lower for most people – monitor the patient for adverse effects (e. If individual cannot resume their standard oral medication submit-operatively and is susceptible https://medeusresearchchem.com/product-category/research-chemicals/